Publications by authors named "Bruno C Medeiros"

100Publications

Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database.

J Manag Care Spec Pharm 2020 Jul 13;26(7):849-859. Epub 2020 Apr 13.

Health Economics & Outcomes Research, Real-World Evidence, IQVIA, Plymouth Meeting, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18553/jmcp.2020.19220DOI Listing
July 2020

Functional characterization of two rare BCR-FGFR1 leukemias.

Cold Spring Harb Mol Case Stud 2020 04 1;6(2). Epub 2020 Apr 1.

Department of Medicine-Hematology, Stanford University, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a004838DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133745PMC
April 2020

Optimizing survival outcomes with post-remission therapy in acute myeloid leukemia.

Am J Hematol 2019 07 1;94(7):803-811. Epub 2019 May 1.

University of Colorado School of Medicine, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25484DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593671PMC
July 2019

Treatment patterns in patients with acute myeloid leukemia in the United States: a cross-sectional, real-world survey.

Curr Med Res Opin 2019 05 19;35(5):927-935. Epub 2019 Mar 19.

b Health Economics and Outcomes Research, Astellas Pharma, Inc. , Northbrook , IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2019.1578152DOI Listing
May 2019

Is there a standard of care for relapsed AML?

Authors:
Bruno C Medeiros

Best Pract Res Clin Haematol 2018 12 20;31(4):384-386. Epub 2018 Sep 20.

Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA 94305-6555, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2018.09.006DOI Listing
December 2018

Functional genomic landscape of acute myeloid leukaemia.

Nature 2018 10 17;562(7728):526-531. Epub 2018 Oct 17.

Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41586-018-0623-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280667PMC
October 2018

Chemotherapy based combinations in AML: Time to take a step back?

Authors:
Bruno C Medeiros

Leuk Res 2018 10 31;73:39-40. Epub 2018 Aug 31.

Stanford University School of Medicine, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.08.018DOI Listing
October 2018

Non-zero-sum game of transfusions: EOL in leukemia.

Authors:
Bruno C Medeiros

Blood 2018 08;132(7):676-678

Stanford University School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-06-856336DOI Listing
August 2018

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia.

J Clin Oncol 2018 09 19;36(26):2684-2692. Epub 2018 Jul 19.

Jeffrey E. Lancet, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Geoffrey L. Uy, Washington University School of Medicine, St Louis, MO; Jorge E. Cortes, The University of Texas MD Anderson Cancer Center, Houston, TX; Laura F. Newell, Oregon Health & Science University, Portland, OR; Tara L. Lin, University of Kansas Medical Center, Kansas City, KS; Ellen K. Ritchie, Weill Cornell Medical College, New York; Jonathan E. Kolitz, Northwell Health System, Lake Success; Daniel H. Ryan, University of Rochester, Rochester, NY; Robert K. Stuart, Medical University of South Carolina, Charleston, SC; Stephen A. Strickland, Vanderbilt-Ingram Cancer Center, Nashville, TN; Donna Hogge, Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, British Columbia, Canada; Scott R. Solomon, The Leukemia Program at Northside Hospital Cancer Center Institute, Atlanta, GA; Richard M. Stone, Dana-Farber Cancer Institute, Boston, MA; Dale L. Bixby, University of Michigan, Grass Lake, MI; Gary J. Schiller, University of California-Los Angeles, Los Angeles; Matthew J. Wieduwilt, University of California-San Diego, La Jolla; Kamalika Banerjee, Michael Chiarella, Arthur C. Louie, Jazz Pharmaceuticals, Palo Alto; Bruno C. Medeiros, Stanford University School of Medicine, Stanford, CA; and Antje Hoering, Cancer Research and Biostatistics, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.6112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127025PMC
September 2018

A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia.

Clin Lymphoma Myeloma Leuk 2018 05 2;18(5):346-352.e5. Epub 2018 Mar 2.

Division of Blood and Marrow Transplantation, Department of Medicine, University of California, San Diego, Moores Cancer Center, La Jolla, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.02.017DOI Listing
May 2018

Interpretation of clinical endpoints in trials of acute myeloid leukemia.

Authors:
Bruno C Medeiros

Leuk Res 2018 05 7;68:32-39. Epub 2018 Feb 7.

Department of Medicine, Stanford University School of Medicine, 875 Blake Wilbur Dr, Stanford, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.02.002DOI Listing
May 2018

Cardiovascular, pulmonary, and metabolic toxicities complicating tyrosine kinase inhibitor therapy in chronic myeloid leukemia: Strategies for monitoring, detecting, and managing.

Blood Rev 2018 07 3;32(4):289-299. Epub 2018 Feb 3.

University of South Florida and H. Lee Moffitt Cancer and Research Institute, 2 Tampa General Circle, Tampa, FL, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0268960X173014
Publisher Site
http://dx.doi.org/10.1016/j.blre.2018.01.004DOI Listing
July 2018

Effects of Education and Income on Treatment and Outcome in Patients With Acute Myeloid Leukemia in a Tax-Supported Health Care System: A National Population-Based Cohort Study.

J Clin Oncol 2017 Nov 11;35(32):3678-3687. Epub 2017 Sep 11.

Lene Sofie Granfeldt Østgård, Mette Nørgaard, and Jan Maxwell Nørgaard, Aarhus University Hospital, Aarhus; Lone Smidstrup Friis, The University Hospital Rigshospitalet, Copenhagen; Claudia Schoellkopf, Herlev Hospital, Herlev; Marianne Tang Severinsen, Aalborg University Hospital, Aalborg; Claus Werenberg Marcher, Odense University Hospital, Odense, Denmark; and Bruno C. Medeiros, Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.6728DOI Listing
November 2017

Long non-coding RNAs: another brick in the wall of normal karyotype acute myeloid leukemia?

Authors:
Bruno C Medeiros

Haematologica 2017 08;102(8):1301-1303

Stanford University School of Medicine, CA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2017.171744DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541864PMC
August 2017

Localized skin-limited blastic plasmacytoid dendritic cell neoplasm: A subset with possible durable remission without transplantation.

JAAD Case Rep 2017 Jul 19;3(4):310-315. Epub 2017 Jul 19.

Department of Dermatology, Stanford Cancer Center, Stanford Hospital and Clinics, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdcr.2017.03.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517837PMC
July 2017

Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function.

Cancer Res 2017 08 26;77(16):4258-4267. Epub 2017 Jun 26.

Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University Knight Cancer Institute, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-1052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763920PMC
August 2017

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.

N Engl J Med 2017 08 23;377(5):454-464. Epub 2017 Jun 23.

From the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston (R.M.S.); the Division of Biomedical Statistics and Informatics (S.J.M., K.L.) and the Alliance Statistics and Data Center (S.J.M., K.L., S.G.), Mayo Clinic, Rochester, MN; the Alliance Statistics and Data Center, Duke University, Durham, NC (B.L.S.); the Ohio State University Comprehensive Cancer Center, Columbus (S.G., C.D.B., T.W.P., G.M., R.B.K.); Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden (C.T., G.E.), Department of Internal Medicine III, University Hospital of Ulm, Ulm (K.D., R.F.S., H.D.), Hematology and Oncology, University of Leipzig, Leipzig (D.N.), Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover (J.K., A.G.), and Department of Medicine II, Hematology-Oncology, Goethe University Hospital Frankfurt, Frankfurt am Main (H.S.) - all in Germany; the Department of Biomedicine and Prevention, University Tor Vergata, Rome (F.L.-C., S.A.); the Department of Clinical Haematology, Alfred Hospital and Monash University, Melbourne, VIC, Australia (A.W.); Hospital de la Santa Creu i Sant Pau, Hematology Department, Autonomous University of Barcelona, Barcelona (J.S.), and Hospital Universitario la Fe, Hematology Department, Department of Medicine, University of Valencia, Valencia (M.A.S.) - both in Spain; the Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto (J.M.B.); Radboud Institute Molecular Studies, Radboud University Medical Center, Nijmegen, the Netherlands (T.W.); the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle (F.R.A.); the Division of Hematology-Oncology, Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA (B.C.M.); the Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (M.S.T.); and the Department of Medicine, University of Chicago, Chicago (R.A.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1614359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754190PMC
August 2017

Novel Therapeutics in Acute Myeloid Leukemia.

Am Soc Clin Oncol Educ Book 2017 ;37:495-503

From the Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175401DOI Listing
December 2017

Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia.

Cell Rep 2017 03;18(13):3204-3218

Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2017.03.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437102PMC
March 2017

NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.

J Natl Compr Canc Netw 2016 11;14(11):1357-1370

From St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; University of Michigan Comprehensive Cancer Center; Fox Chase Cancer Center; UC San Diego Moores Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; City of Hope Comprehensive Cancer Center; Duke Cancer Institute; University of Colorado Cancer Center; The University of Texas MD Anderson Cancer Center; Moffitt Cancer Center; Fred & Pamela Buffett Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; Mayo Clinic Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; Memorial Sloan Kettering Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Stanford Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Roswell Park Cancer Institute; UCSF Helen Diller Family Comprehensive Cancer Center; Huntsman Cancer Institute at the University of Utah; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; Consultant; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0146DOI Listing
November 2016

Why do subjects on clinical trials discontinue therapy? Do we really know?

Leuk Res 2016 12 17;51:19-21. Epub 2016 Oct 17.

Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, SW7 2AZ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.10.006DOI Listing
December 2016

Management of invasive Aspergillosis in acute myelogenous leukemia.

Authors:
Bruno C Medeiros

Clin Adv Hematol Oncol 2016 Jul;14(7):502-4

Stanford University School of Medicine, Stanford, California.

View Article

Download full-text PDF

Source
July 2016

A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma.

Br J Haematol 2016 Apr 4;173(2):253-9. Epub 2016 Apr 4.

Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13946DOI Listing
April 2016

Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.

Blood 2016 Feb 28;127(8):1017-23. Epub 2015 Dec 28.

Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia; School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide, SA, Australia; School of Medicine, University of Adelaide, Adelaide, SA, Australia; School of Molecular and Biological Sciences, University of Adelaide, Adelaide, SA, Australia; Australian Cancer Research Foundation Cancer Genomics Facility, Centre for Cancer Biology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-10-676098DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968341PMC
February 2016

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Myeloproliferative Neoplasms.

Arch Pathol Lab Med 2016 Jul 11;140(7):675-7. Epub 2015 Dec 11.

From the Department of Pathology, University of Utah, Salt Lake City (Dr Kelley); the Departments of Pathology (Drs Arber and Zehnder) and Medicine (Dr Medeiros), Stanford University School of Medicine, Stanford, California; the Blood and Marrow Transplantation Program, Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Pathology, Ohio State University, Columbus (Dr Jones); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); the Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts (Dr Pilichowska); the Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Vasef); and the Department of Pathology, Intermountain Healthcare, Salt Lake City, Utah (Dr Wallentine).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2015-0400-CPDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409812PMC
July 2016

Template for Reporting Results of Monitoring Tests for Patients With Chronic Myelogenous Leukemia (BCR-ABL1(+)).

Arch Pathol Lab Med 2016 Jul 11;140(7):672-4. Epub 2015 Dec 11.

From the Department of Pathology, University of Utah, Salt Lake City (Dr Kelley); the Departments of Pathology (Drs Arber and Zehnder) and Medicine (Dr Medeiros), Stanford University School of Medicine, Stanford, California; the Blood and Marrow Transplantation Program, Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Pathology, Ohio State University, Columbus (Dr Jones); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); the Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts (Dr Pilichowska); the Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Vasef); and the Department of Pathology, Intermountain Healthcare, Salt Lake City, Utah (Dr Wallentine).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2015-0399-CPDOI Listing
July 2016

Selective Toxicity of Investigational Ixazomib for Human Leukemia Cells Expressing Mutant Cytoplasmic NPM1: Role of Reactive Oxygen Species.

Clin Cancer Res 2016 Apr 3;22(8):1978-88. Epub 2015 Dec 3.

Division of Hematology, Department of Medicine, Stanford University, Stanford, California. Stanford Cancer Institute, Stanford University, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1440DOI Listing
April 2016

Chemotherapy options for previously untreated acute myeloid leukemia.

Expert Opin Pharmacother 2015 ;16(14):2149-62

a Stanford University, Division of Hematology, Department of Medicine , Stanford, CA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2015.1076795DOI Listing
December 2015

Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.

J Clin Oncol 2015 Nov 24;33(31):3641-9. Epub 2015 Aug 24.

Lene Sofie Granfeldt Østgård, Mette Nørgaard, Eigil Kjeldsen, and Jan Maxwell Nørgaard, Aarhus University Hospital, Aarhus; Henrik Sengeløv, Mette Klarskov Andersen, and Lone Smidstrup Friis, The University Hospital Rigshospitalet, Copenhagen; Inge Høgh Dufva, Herlev University Hospital, Herlev; Claus Werenberg Marcher and Birgitte Preiss, Odense University Hospital, Odense; Marianne Severinsen, Aalborg University Hospital, Aalborg, Denmark; and Bruno C. Medeiros, Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.60.0890
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.60.0890DOI Listing
November 2015

Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy.

Cancer Discov 2015 Sep 19;5(9):988-1003. Epub 2015 Jun 19.

Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-15-0298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652947PMC
September 2015

Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia.

Nat Med 2015 Feb 19;21(2):178-84. Epub 2015 Jan 19.

1] Department of Medicine, Stanford University School of Medicine, Stanford, California, USA. [2] Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.3788DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406275PMC
February 2015

Monosomal karyotype acute myeloid leukemia: tread lightly.

Acta Haematol 2015 4;133(4):324-6. Epub 2014 Dec 4.

Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, Calif., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000368213DOI Listing
June 2015

Chemotherapy dose in obese AML patients: to cap or not to cap?

Leuk Res 2015 Jan 7;39(1):30-2. Epub 2014 Nov 7.

Division of Hematology, Stanford University School of Medicine, Stanford, CA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.10.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5158098PMC
January 2015

Increased plasma d-2-hydroxyglutarate in isocitrate dehydrogenase 2-mutated blastic plasmacytoid dendritic cell neoplasm.

Hum Pathol 2015 Feb 4;46(2):322-6. Epub 2014 Nov 4.

Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00468177140044
Publisher Site
http://dx.doi.org/10.1016/j.humpath.2014.10.013DOI Listing
February 2015

Management considerations in older patients with AML: a 2014 perspective.

Authors:
Bruno C Medeiros

Rinsho Ketsueki 2014 10;55(10):1803-7

Stanford University School of Medicine.

View Article

Download full-text PDF

Source
October 2014

Polypharmacy in AML: the tip of the iceberg.

Leuk Res 2014 Nov 5;38(11):1378-9. Epub 2014 Oct 5.

Stanford University, Department of Medicine, Division of Hematology, Stanford, CA 94305, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.09.009DOI Listing
November 2014

Mcl-1 dependence predicts response to vorinostat and gemtuzumab ozogamicin in acute myeloid leukemia.

Leuk Res 2014 May 28;38(5):564-8. Epub 2014 Feb 28.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, United States; Department of Epidemiology, University of Washington, Seattle, WA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.02.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104771PMC
May 2014

Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission.

Proc Natl Acad Sci U S A 2014 Feb 3;111(7):2548-53. Epub 2014 Feb 3.

Program in Cancer Biology, Ludwig Center, Cancer Institute, Institute for Stem Cell Biology and Regenerative Medicine, and Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA 94305.

View Article

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.1324297111
Publisher Site
http://dx.doi.org/10.1073/pnas.1324297111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932921PMC
February 2014

Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia.

Br J Haematol 2014 Jan 28;164(2):245-50. Epub 2013 Oct 28.

Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12625DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117470PMC
January 2014

Facts about FCE (fludarabine, cytarabine, etoposide) in acute myeloid leukemia.

Authors:
Bruno C Medeiros

Acta Haematol 2014 27;131(4):200-1. Epub 2013 Nov 27.

Stanford University School of Medicine, Stanford, Calif., USA.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/355134
Publisher Site
http://dx.doi.org/10.1159/000355134DOI Listing
July 2014

Qualitative analysis of practicing oncologists' attitudes and experiences regarding collection of patient-reported outcomes.

J Oncol Pract 2013 Nov 6;9(6):e290-7. Epub 2013 Aug 6.

University of Michigan, Ann Arbor, MI; Yale Cancer Center, New Haven, CT; University of Chicago, Chicago, IL; Stanford University, Stanford, CA; American Society of Clinical Oncology, Alexandria, VA; Duke University, Durham, NC; Michiana Hematology/Oncology, South Bend; and Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2012.000823DOI Listing
November 2013

A single-center experience of the nationwide daunorubicin shortage: substitution with doxorubicin in adult acute lymphoblastic leukemia.

Leuk Lymphoma 2013 Oct 8;54(10):2231-5. Epub 2013 Mar 8.

Department of Pharmacy, Stanford Hospital, Stanford University Medical Center , Stanford, CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.772606DOI Listing
October 2013

CD11b expression and MK+ AML: a sign of impending doom?

Authors:
Bruno C Medeiros

Leuk Res 2013 Feb 10;37(2):121. Epub 2012 Nov 10.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2012.10.013DOI Listing
February 2013

New Treatment Approaches for Older Adults with Multiple Myeloma.

J Geriatr Oncol 2012 Jul 28;3(3):279-290. Epub 2012 Feb 28.

Washington University School of Medicine, St Louis MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2012.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458649PMC
July 2012

Novel agents in acute myeloid leukemia.

Int J Hematol 2012 Aug 6;96(2):178-85. Epub 2012 Aug 6.

Stanford University School of Medicine, Stanford, CA 94305-5821, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-012-1151-5DOI Listing
August 2012

Aggressive EBV-associated lymphoproliferative disorder: a prodrome to diffuse large B-cell lymphoma?

Appl Immunohistochem Mol Morphol 2012 May;20(3):325-30

Department of Pathology and Internal Medicine, Stanford University School of Medicine, Stanford, CA 94305-5324, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0b013e318233d72aDOI Listing
May 2012

Blood consult: monosomal karyotype acute myeloid leukemia.

Blood 2012 Jun 12;119(24):5659-60. Epub 2012 Apr 12.

Stanford University School of Medicine, Stanford, CA 94305-5281, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-01-405225DOI Listing
June 2012

Unveiling the complexity of CK+ AML.

Authors:
Bruno C Medeiros

Blood 2012 Mar;119(9):1958-9

Stanford University School of Medicine.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-01-40
Publisher Site
http://dx.doi.org/10.1182/blood-2012-01-401505DOI Listing
March 2012

"It doesn't matter if you're black or white", does it?

Authors:
Bruno C Medeiros

Leuk Res 2012 Feb 21;36(2):127. Epub 2011 Nov 21.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.10.028DOI Listing
February 2012

Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia.

Am J Hematol 2012 Jan 4;87(1):45-50. Epub 2011 Nov 4.

Department of Medicine, Division of Hematology, Stanford University School of Medicine, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.22191DOI Listing
January 2012